WALTER H. MOOS, PH.D. - Corporate Board Profile

RIGEL PHARMACEUTICALS INC

Filing Date	Source Excerpt
2006-04-25	Walter H. Moos, Ph.D., age 51, joined us as a director in March 1997. In March 2005, Dr. Moos joined SRI International, an independent nonprofit research institute, as head of the biosciences division. ... Dr. Moos holds an A.B. from Harvard University and a Ph.D. in chemistry from the University of California, Berkeley.
2007-03-26	Walter H. Moos, Ph.D., age 52, joined us as a director in March 1997. In March 2005, Dr. Moos joined SRI International, an independent nonprofit research institute, as Vice President of the biosciences division. ... The following table shows for the fiscal year ended December 31, 2006 certain information with respect to the compensation of all non-employee directors of the Company: DIRECTOR COMPENSATION FOR FISCAL 2006 ... Walter H. Moos Fees Earned or Paid in Cash ($) 30,000 Option Awards ($) 57,079 Total ($) 87,079
2008-04-08	Walter H. Moos, Ph.D., age 53, joined us as a director in March 1997. ... Dr. Moos serves on the Board of Directors of MIGENIX Inc. ... The Compensation Committee comprises three directors: Drs. Moos and Deleage and Mr. Lyons. ... The Compensation Committee met five times during fiscal year 2007. ... The following table shows for the fiscal year ended December 31, 2007 certain information with respect to the compensation of all non-employee directors of the Company: Walter H. Moos, Ph.D. $54,500 Fees Earned or Paid in Cash, $56,969 Option Awards, Total $111,469.
2009-04-15	Walter H. Moos, Ph.D., age 54, joined us as a director in March 1997. ... The following three directors are the members of the Audit Committee: Messrs. Goodwin and Renton and Dr. Sherwin, all of whom were on the Audit Committee for all of fiscal year 2008. ... The following three directors are the members of the Compensation Committee: Drs. Moos and Deleage and Mr. Lyons, all of whom were on the Compensation Committee for all of fiscal year 2008. ... The following three directors are the members of the Nominating and Corporate Governance Committee: Drs. Moos, Sherwin and Ringrose, all of whom were on the Nominating and Corporate Governance Committee for all of fiscal year 2008. ... For services provided in 2008, each non-employee director of Rigel received a yearly retainer of $30,000, ... In the fiscal year ended December 31, 2008, the total cash compensation earned by non-employee directors was $203,760.
2010-04-12	Walter H. Moos, Ph.D., age 55, joined us as a director in March 1997. The Nominating and Corporate Governance Committee concluded that Dr. Moos continues to be a valuable member of the Board in part due to his extensive leadership skills and operational expertise, as well as his expertise in the chemical sciences, which is particularly relevant to our business as we are a company focused on small molecules. In March 2005, Dr. Moos joined SRI International, an independent nonprofit research institute, as head of the biosciences division. From 1997 to 2004, Dr. Moos served as the Chairman and Chief Executive Officer of MitoKor, Inc., a biotechnology company. From 1991 to 1997, he served as Corporate Vice President and Vice President, Research and Development in the Technologies Division of Chiron Corporation, a biotechnology company. From 1982 to 1991, Dr. Moos held several positions at the Parke-Davis Pharmaceutical Research Division of the Warner-Lambert Company, last holding the position of Vice President, Neuroscience and Biological Chemistry. He has been an Adjunct Professor at the University of California, San Francisco, since 1992. Dr. Moos served on the Board of Directors of MIGENIX Inc. from 2004 to 2008. He has also served on the boards of numerous private companies and several non-profit organizations. Dr. Moos has been an advisor to the National Academy of Sciences and venture capital firms. He also has served as an adjunct faculty member at the University of Michigan and at James Madison University. Dr. Moos holds an A.B. from Harvard University and a Ph.D. in Chemistry from the University of California, Berkeley. DIRECTOR COMPENSATION FOR FISCAL YEAR 2009 The following table shows for the fiscal year ended December 31, 2009 certain information with respect to the compensation of all non-employee directors of the Company: Walter H. Moos, Ph.D. $56,000 Fees Earned or Paid in Cash Option Awards $59,159 Total $115,159
2011-04-04	Walter H. Moos, Ph.D., age 56, joined us as a director in March 1997. The Board concluded that Dr. Moos should continue to serve as a member of the Board in part due to his extensive leadership skills and operational expertise, as well as his expertise in the chemical sciences, which is particularly relevant to our business as we are a company focused on small molecules. ... The following table shows the compensation of all non-employee directors of the Company for the fiscal year ended December 31, 2010: Walter H. Moos, Ph.D. $60,000 Option Awards $75,390 Total $135,390
2012-04-12	Walter H. Moos, Ph.D., age 57, joined us as a director in March 1997. ... The Board has four standing committees: ... Audit Committee, Compensation Committee ... The following three directors are the members of the Compensation Committee: Mr. Lyons and Drs. Moos and Ringrose. ... For services provided in 2011, each non-employee director of Rigel received a yearly retainer of $30,000, ... In the fiscal year ended December 31, 2011, the total cash compensation earned by non-employee directors was $375,750. ... The following table shows the compensation of all non-employee directors of the Company for the fiscal year ended December 31, 2011: ... Walter H. Moos, Ph.D. ... Total $152,299.
2013-04-03	Walter H. Moos, Ph.D., age 58, joined us as a director in March 1997. The Board concluded that Dr. Moos continues to be a valuable member of the Board in part due to his extensive leadership skills and operational expertise, as well as his expertise in the chemical sciences, which is particularly relevant to our business as we are a company focused on small molecules. ... The following table shows the compensation of all non-employee directors of the Company for the fiscal year ended December 31, 2012: Bradford S. Goodwin 67,000 76,760 143,760 Gary A. Lyons 65,000 76,760 141,760 Walter H. Moos, Ph.D. 65,000 76,760 141,760 Hollings C. Renton 57,000 76,760 133,760 Peter S. Ringrose, Ph.D. 67,500 76,760 144,260 Stephen A. Sherwin, M.D. 72,000 76,760 148,760
2014-04-08	Walter H. Moos, Ph.D., age 59, joined us as a director in March 1997. The Board concluded that Dr. Moos continues to be a valuable member of the Board in part due to his extensive leadership skills and operational expertise, as well as his expertise in the chemical sciences, which is particularly relevant to our business as we are a company focused on small molecules. ... In 2013, each non-employee director who continued to serve as a non-employee director automatically received, under the Directors' Plan, an annual option grant to purchase 15,000 shares of common stock, as further described below. ... On May 15, 2013, pursuant to the Directors' Plan, we granted options to purchase 15,000 shares of common stock to Walter H. Moos, each at an exercise price of $4.87 per share. These options vest in 12 equal monthly installments beginning on the grant date. ... The following table shows the compensation of all non-employee directors of the Company for the fiscal year ended December 31, 2013: Walter H. Moos, Ph.D. Fees Earned or Paid in Cash ($) 65,000 Option Awards ($) 51,477 Total ($) 116,477
2015-03-30	Walter H. Moos, Ph.D., age 60, joined us as a director in March 1997. ... Dr. Moos was appointed Chairperson of the Compensation Committee effective April 1, 2015. ... The following table shows the compensation of all non-employee directors of the Company for the fiscal year ended December 31, 2014: ... Walter H. Moos, Ph.D. 65,000 70,326 135,326 ...
2016-03-28	Walter H. Moos, Ph.D., age 61, joined us as a director in March 1997. ... Dr. Moos was Chair of the Nominating and Corporate Governance Committee for the first meeting of 2015. ... The following table shows the compensation of all non-employee directors of the Company for the fiscal year ended December 31, 2015: ... Walter H. Moos, Ph.D. Fees Earned or Paid in Cash $67,500, Option Awards $158,400, Total $225,900.
2017-03-29	Walter H. Moos, Ph.D., age 62, joined us as a director in March 1997. ... The Board concluded that Dr. Moos should continue to serve as a member of the Board ... The members of our Compensation Committee are Dr. Walter H. Moos, Mr. Gary A. Lyons and Mr. Keith A. Katkin. ... The following table shows the compensation of all non-employee directors of the Company for the fiscal year ended December 31, 2016: Walter H. Moos, Ph.D. Fees Earned or Paid in Cash $75,000, Option Awards $57,148, Total $132,148.
2019-04-09	Walter H. Moos, Ph.D., age 64, joined us as a director in March 1997. ... The following three directors are the current members of the Audit Committee: Mr. Goodwin, Mr. Katkin and Mr. Lapointe. ... The following three directors are the members of the Compensation Committee: Mr. Lyons, Mr. Katkin and Dr. Moos. ... The following three directors were members of the Finance Committee for all of 2018: Mr. Lyons, Mr. Rodriguez and Mr. Goodwin. ... The following table shows the compensation of all non-employee directors of the Company for the fiscal year ended December 31, 2018: Walter H. Moos, Ph.D. 85,000 fees earned in cash, 103,664 option awards, total 188,664.
2020-04-01	Walter H. Moos, Ph.D., age 65, joined us as a director in March 1997. ... The Board concluded that Dr. Moos should continue to serve as a member of the Board ... The following three directors are the members of the Compensation Committee: Dr. Moos, Mr. Lyons and Mr. Katkin. Dr. Moos serves as Chair. ... For services provided in 2019, each non-employee director received, paid on a quarterly basis for quarters served, a yearly retainer of $50,000. ... Each non-employee director receives stock option grants under our 2018 Plan. ... The following table shows the compensation of all non-employee directors of the Company for the fiscal year ended December 31, 2019: Walter H. Moos, Ph.D. Fees Earned or Paid in Cash $75,000, Option Awards $22,917, Total $97,917.
2022-04-05	Walter H. Moos, Ph.D., age 67, joined us as a director in March 1997. Since October 2018, Dr. Moos has been managing director of Pandect Bioventures, a venture capital firm investing in therapeutics and biotechnologies. ... Dr. Moos was selected to serve as a member of the Board in part due to his extensive leadership skills and operational expertise, as well as his expertise in the chemical sciences, which is particularly relevant to our business as we are a company focused on small molecules.
2023-04-14	Walter H. Moos, Ph.D., age 68, joined us as a director in March 1997. ... Dr. Moos was selected to serve as a member of the Board in part due to his extensive leadership skills and operational expertise, as well as his expertise in the chemical sciences, which is particularly relevant to our business as we are a company focused on small molecules. ... The following directors are currently members of the Compensation Committee: Dr. Moos ... The following directors are currently members of the Scientific and Clinical Trial Advisory Committee: Dr. Moos ... The following table shows the compensation of all non-employee directors of the Company for the fiscal year ended December 31, 2022: Walter H. Moos, Ph.D. Fees Earned or Paid in Cash ($) 75,000 Stock Awards ($) 50,250 Option Awards ($) 40,926 Total ($) 166,176.